Skip to main content
EvokAI Creative Labs Inc. logo

EvokAI Creative Labs Inc. — Investor Relations & Filings

Ticker · OKAI ISIN · CA30053J1012 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 92 across all filing types
Latest filing 2024-11-28 Regulatory Filings
Country CA Canada
Listing TSXV OKAI

About EvokAI Creative Labs Inc.

www.evokailabs.com

EvokAI Creative Labs Inc. is a MedTech artificial intelligence (AI)-powered company dedicated to developing transformational technologies for the modern healthcare sector. The company specializes in deploying machine learning models and advanced software solutions to analyze medical data, uncover critical insights, and integrate novel findings. EvokAI focuses on neurotechnology, aiming to provide data-driven platforms that enhance healthcare delivery and research.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 72% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” under Canadian NI 52-109 rules. It is a required regulatory certificate by the CFO attesting to the completeness and fairness of the interim financial report and MD&A. It does not itself contain the interim financial statements or MD&A, nor is it an announcement of report publication; rather, it is a standalone regulatory certification. This best aligns with the fallback category for miscellaneous regulatory filings.
2024-11-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 90% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” under Canadian NI 52-109, signed by the CEO certifying the interim financial report and MD&A. It is not the interim report itself but a required regulatory certificate. It does not present financial data or discussion, so it does not qualify as an IR (Interim/Quarterly Report) or MDA. It is a specific compliance filing under securities regulation and best fits the general Regulatory Filings category.
2024-11-28 English
Interim MD&A - English.pdf
Management Reports Classification · 87% confidence The document is titled “Management’s Discussion and Analysis for the nine months ended September 30, 2024.” It contains forward‐looking statements, overview, outlook, and detailed commentary on operating results without full financial statements, fitting the Management’s Discussion and Analysis narrative. This aligns with the “Management Reports” category (MDA), which covers management’s detailed explanation of financial results, business trends, and outlook, rather than a full interim report (IR) or an announcement.
2024-11-28 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed consolidated interim financial statements' for EvokAI Creative Labs Inc. for the nine months ended September 30, 2024. It includes detailed financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Changes in Shareholders' Equity, and Statement of Cash Flows) along with comprehensive notes. This meets the definition of an Interim/Quarterly Report (IR) as it contains substantive financial data and analysis for a period shorter than a full fiscal year. 9M 2024
2024-11-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'Pricing Supplement No. 2,832' and references a 'Short Form Base Shelf Prospectus dated October 7, 2022.' It details the terms, conditions, pricing, and structure of a specific note issuance by Canadian Imperial Bank of Commerce (CIBC). The content includes detailed financial terms, issue size, pricing, returns, and index references related to a structured note offering. This type of document is a supplement to a prospectus and is used to provide specific pricing and offering details for a securities issuance. It is not a financial report, earnings release, or regulatory filing but rather a capital markets document related to financing activities. Therefore, it fits the category of a Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed financial and offering information, not merely an announcement or certification, so it is not RPA or RNS.
2024-08-23 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management’s Discussion and Analysis for the six months ended June 30, 2024' and dated August 23, 2024. It contains detailed discussion of the company's financial condition, operating results, acquisitions, and outlook for the interim period ending June 30, 2024. It references unaudited condensed consolidated interim financial statements prepared under IFRS and IAS 34, which governs interim financial reporting. The content includes substantive financial and operational data for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. The document is approximately 15,000 characters, indicating it is a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2024-08-23 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.